相关实验视频

Updated: Sep 13, 2025

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

在急性心肌梗塞中超氧氧疗法:机制,有效性和未来方向

Uttam Kalluri¹, William Frishman^1,2

¹From the New York Medical College, School of Medicine, Valhalla, NY.

Cardiology in review

|July 25, 2025

概括

超和氧 (SSO2) 疗法在与皮肤冠状动脉干预相结合时,显示出作为冠状动脉疾病 (CAD) 辅助治疗的前景. 虽然存在潜在的自由基损害,但它可以被管理,支持对这种疗法的进一步临床研究.

科学领域:

心血管医学心血管医学
生物医学工程生物医学工程
再生医学是一种再生医学.

背景情况:

冠状动脉疾病 (CAD) 仍然是全球死亡的主要原因.
穿皮冠状动脉干预 (PCI) 是急性CAD事件的主要治疗方法.
寻求辅助疗法来改善PCI后的结果.

研究的目的:

评估超和氧 (SSO2) 治疗作为CAD的辅助治疗的潜力.
探索SSO2治疗与PCI结合的疗效和安全性.
审查从动物模型和临床试验中获得的关于在CAD中SSO2治疗的证据.

主要方法:

动物研究的审查,特别是猪模型,调查SSO2治疗CAD和心肌梗塞.
对临床试验数据的分析表明,SSO2疗法在特定的CAD患者群体中具有益处,例如前侧ST升高心肌梗塞.
考虑与SSO2治疗相关的潜在不良影响,包括自由基的产生.

主要成果:

动物模型表明SSO2疗法在治疗CAD和心肌梗塞方面具有潜在的益处.
临床试验表明,SSO2疗法对前部ST段升高心肌梗塞患者有益.
一个关键的问题是潜在的自由基生产,这可能会损害组织愈合.

结论:

作为PCI的辅助剂的SSO2疗法,需要认真考虑CAD治疗.
药理干预可以减轻与SSO2诱导的自由基产生相关的风险.
建议进一步调查SSO2治疗在CAD管理中的临床效用.

关键词:

剧烈的心肌梗塞急性心肌梗塞冠状动脉疾病是一种冠状动脉疾病.通过皮肤进行冠状动脉干预.转流是指转流的意思,是指转流的意思,是指转流的意思.超和氧疗法是一种超和氧疗法.

更多相关视频

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

相关概念视频

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Acute Coronary Syndrome V: Nursing Management

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...